Sunday, December 16, 2012
Dementia & Alzheimer's Weekly: Solanezumab, a Top Alzheimer's Experimental Drug, ...
Dementia & Alzheimer's Weekly: Solanezumab, a Top Alzheimer's Experimental Drug, ...: VIDEO & ARTICLE Solanezumab slowed Alzheimer's by 30% in a trial earlier this year. Find out what it's maker, Ely Lilly, plans for the nex...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment